NovaBay Pharmaceuticals Dividends
| NBY Stock | USD 0.51 0.03 4.95% |
Dividend Paid And Capex Coverage Ratio is likely to rise to -943.74 in 2026. NovaBay Pharmaceuticals' past performance could be the main factor of why investors trade NovaBay Pharmaceuticals stock today. Investors should clearly understand every aspect of the NovaBay Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest NovaBay Pharmaceuticals' dividend schedule and payout information. NovaBay Pharmaceuticals dividends can also provide a clue to the current valuation of NovaBay Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (993.41) | (943.74) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in NovaBay Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
NovaBay Pharmaceuticals Past Distributions to stockholders
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. Anticipated expansion of NovaBay directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive NovaBay Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 5.16 | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
NovaBay Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on NovaBay's balance sheet. Smart investors calculate NovaBay Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since NovaBay Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between NovaBay Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NovaBay Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.